1 September 2024

Starpharma to present at Finance News Network Investor Event

Melbourne, Australia; 24 August 2017: Starpharma (ASX: SPL, OTCQX: SPHRY) is presenting today at the Finance News Network (FNN) Investor event in Sydney.

The FNN Investor Event is designed to engage with the investment community and brings together ASX-listed entities, investors, stockbrokers and fund managers. Starpharma’s 15‑minute presentation by Dr Jackie Fairley, Chief Executive Officer, primarily focuses on recent announcements, including the Company’s successful phase 3 trials for VivaGel® BV and the sale of its agrochemicals business.

The presentation commences at 1:15pm at the Radisson Blu Plaza Hotel on O’Connell Street, Sydney.

 

View presentation: Starpharma's FNN Presentation (pdf file, 1.9MB)

Download announcement: Starpharma to present at Finance News Network Investor Event (pdf file, 123kb)

This contains certain forward-looking statements.

Important Notice

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.